Advertisement

American Journal of Clinical Dermatology

, Volume 2, Issue 3, pp 131–134 | Cite as

Photoprotection by Sunscreens

  • Lubomira Scherschun
  • Henry W. LimEmail author
Current Opinion

Abstract

Ultraviolet (UV) radiation is an etiologic factor for the development of nonmelanoma skin cancers and also possibly melanoma. The American Academy of Dermatology currently recommends the daily use of sunscreens with a sun protection factor (SPF) of 15 or above. The SPF numerical rating is an in vivo, standardized measure of sunscreen efficacy. SPF assessment predominantly reflects the ability of a product to screen UVB radiation. The physical and biologic properties of UVA radiation are relevant as UVA contributes to photoimmunosuppression and photocarcinogenesis. An ideal sunscreen assessment system would address both UVB and UVA protection. However, the SPF rating should continue to serve as the major determinant of sunscreen efficacy.

Keywords

Actinic Keratose Nonmelanoma Skin Cancer Minimal Erythema Dose Urocanic Acid Sunscreen Product 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Skin Cancer Foundation website. Available from URL: http//skincancer.org. Accessed 2000, October 14Google Scholar
  2. 2.
    American Melanoma Foundation website. Available from URL: http//melanomafoundation.org. Accessed 2000, October 15Google Scholar
  3. 3.
    Griffin M.E., Bourget T.D., Lowe N.J. Sun protection factor determination in the United States. In: Lowe N.J., Shaath N.A., Pathak M.A., editors. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997: 499–512Google Scholar
  4. 4.
    Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170–175PubMedCrossRefGoogle Scholar
  5. 5.
    Thompson S.C., Jolley D., Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329 (16): 1147–1151PubMedCrossRefGoogle Scholar
  6. 6.
    Gallagher R.P., Rivers J.K., Lee T.K., et al. Broad-spectrum sunscreen use and the development of new nevi in white children. JAMA 2000; 22: 2955–2960CrossRefGoogle Scholar
  7. 7.
    Pruim B., Green A. Photobiological aspects of sunscreen re-application. Aust J Dermatol 1999; 40 (1): 14–18CrossRefGoogle Scholar
  8. 8.
    Wulf H.C., Stender I.M., Lock-Anderson J. Sunscreens used at the beach do not protect against erythema: a new definition of SPF is proposed. Photodermatol Photoimmunol Photomed 1997; 13 (4): 129–132PubMedCrossRefGoogle Scholar
  9. 9.
    Stenberg C., Larko O. Sunscreen application and its importance for the sun protection factor. Arch Dermatol 1985; 121 (11): 1400–1402PubMedCrossRefGoogle Scholar
  10. 10.
    Westerdahl J., Olsson H., Masback A., et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995; 5: 59–65PubMedCrossRefGoogle Scholar
  11. 11.
    Huncharek M., Kupelnick B. Use of topical sunscreen and the risk of malignant melanoma. Results of a meta-analysis of 9,067 patients. Ann Epidemiol 2000; 10 (7): 467PubMedCrossRefGoogle Scholar
  12. 12.
    Bigby M. The sunscreen and melanoma controversy. Arch Dermatol 2000; 136 (3): 423CrossRefGoogle Scholar
  13. 13.
    Kochevar I.E., Pathak M.A., Parrish J.A. Photophysics, photochemistry and photobiology. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Dermatology in general medicine. 5th ed. New York: McGraw-Hill Inc., 1999: 220–229Google Scholar
  14. 14.
    Fourtanier A., Gueniche A., Compan D., et al. Improved protection against solar-simulated radiation-induced immunosuppression by a sunscreen with enhanced ultraviolet A protection. J Invest Dermatol 2000; 114: 620–627PubMedCrossRefGoogle Scholar
  15. 15.
    Van der Molen R.G., Out-Luiting C., Driller H., et al. Broad-spectrum sunscreens offer protection against urocanic acid photoisomeration by artificial ultraviolet radiation in human skin. J Invest Dermatol 2000; 115 (3): 421–426PubMedCrossRefGoogle Scholar
  16. 16.
    Setlow R.B., Grist E., Thompson K., et al. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci 1993; 90: 6666–6670PubMedCrossRefGoogle Scholar
  17. 17.
    Freeman S.E., Gange R.W., Sutherland J.C., et al. Production of pyrimidine dimers in DNA of human skin exposed in situ to UVA radiation. J Invest Dermatol 1987; 88 (4): 430–433PubMedCrossRefGoogle Scholar
  18. 18.
    Drobetsky E.A., Turcotte J., Chateauneuf A. A role for ultraviolet A solar mutagenesis. Proc Natl Acad Sci 1995; 92: 2350–2354PubMedCrossRefGoogle Scholar
  19. 19.
    Lavker R.M., Gerberick G.F., Veres D., et al. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1991; 32: 53–62CrossRefGoogle Scholar
  20. 20.
    Lowe N.J. Ultraviolet A claims and tesing procedures for OTC sunscreens: a summary and review. In: Lowe N.J., Shaath N.A., Pathak M.A., editors. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997: 527–535Google Scholar
  21. 21.
    Chardon A., Moyal D., Hourseau C. Persistent pigment-darkening response as a method for evaluation of ultraviolet A protection assays. In: Lowe N.J., Shaath N.A., Pathak M.A., editors. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997: 559–582Google Scholar
  22. 22.
    Lim HW, Naylor M, Hönigsmann H, et al. American Academy of Dermatology Consensus Conference on UVA Protection of Sunscreens: summary and recommendations. J Am Acad Dermatol [In press]Google Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  1. 1.Department of DermatologyHenry Ford HospitalDetroitUSA

Personalised recommendations